TrueCar (TRUE)
(Delayed Data from NSDQ)
$3.45 USD
+0.01 (0.29%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $3.45 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth D Momentum B VGM
Price, Consensus and EPS Surprise
TRUE 3.45 +0.01(0.29%)
Will TRUE be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for TRUE based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for TRUE
TrueCar (TRUE) Reports Q1 Earnings: What Key Metrics Have to Say
TrueCar (TRUE) Reports Q1 Loss, Lags Revenue Estimates
TRUE: What are Zacks experts saying now?
Zacks Private Portfolio Services
TrueCar (TRUE) Reports Q4 Earnings: What Key Metrics Have to Say
TrueCar (TRUE) Reports Break-Even Earnings for Q4
DoorDash, Inc. (DASH) Reports Q4 Loss, Tops Revenue Estimates
Other News for TRUE
Repeat: Treatment.com AI Provides Latest Corporate Update
Treatment.com AI Provides Latest Corporate Update
Treatment.com AI Plans Share-Based Debt Resolution
Treatment.com AI Partners with Novus Health
Treatment.com AI and Novus Health Partnership Expands Access to its Global Library of Medicine (GLM)